Norharmane

CAS No. 244-63-3

Norharmane( —— )

Catalog No. M18299 CAS No. 244-63-3

Norharmane is a natural β-carboline first isolated from plants of the Zygophyllaceae family.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 28 In Stock
500MG 41 In Stock
1G 57 In Stock

Biological Information

  • Product Name
    Norharmane
  • Note
    Research use only, not for human use.
  • Brief Description
    Norharmane is a natural β-carboline first isolated from plants of the Zygophyllaceae family.
  • Description
    Norharmane is a natural β-carboline first isolated from plants of the Zygophyllaceae family.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Male NMRI mice (22-25?g)Dosage:0, 2.5, 5 and 10?mg/kg Administration:IP, onceResult:Elicited an anxiety- and antidepressant-like behavior, and decreased locomotor activity.
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    JNK
  • Recptor
    DNA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    244-63-3
  • Formula Weight
    168.2
  • Molecular Formula
    C11H8N2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 11 mg/mL (65.40 mM)
  • SMILES
    c12ccccc1c1ccncc1[nH]2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jamali., et al. Inhibitory effect of Rosa rugosa tea extract on the formation of heterocyclic amines in meat patties at different temperatures. Molecules 21(2), 173 (2016).
molnova catalog
related products
  • Tanzisertib

    Tanzisertib (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.Tanzisertib (CC-930) inhibits the formation of phospho-cJun in human PBMC stimulated by phorbol-12-myristate-13-acetate and phytohemeagglutinin (IC50=1 μM)[1] and it blocks the JNK pathway that is activated by pro-fibrotic cytokines in systemic sclerosis.

  • JNK-IN-13

    JNK-IN-13 is a selective and potent JNK inhibitor that inhibits JNK3 and JNK2 and can be used in the study of diabetes, inflammation, and neurological disorders.

  • PIK-293

    PIK-293 is a?PI3K?inhibitor, for?PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.